|
1
|
Pipitone S, Vitale MG, Baldessari C,
Dominici M and Sabbatini R: Long survival of a young patient with
Xp11.2 translocation metastatic clear cell renal carcinoma: Case
report. Tumori. 107:NP131–NP135. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kmetec A and Jeruc J: Xp 11.2
translocation renal carcinoma in young adults; recently classified
distinct subtype. Radiol Oncol. 48:197–202. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Komai Y, Fujiwara M, Fujii Y, Mukai H,
Yonese J, Kawakami S, Yamamoto S, Migita T, Ishikawa Y, Kurata M,
et al: Adult Xp11 translocation renal cell carcinoma diagnosed by
cytogenetics and immunohistochemistry. Clin Cancer Res.
15:1170–1176. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhu Y, Pu X, Dong X, Ji C, Guo H, Li D,
Zhao X and Gan W: Molecular heterogeneity of Xp11.2 translocation
renal cell carcinoma: The correlation between split signal pattern
in fish and prognosis. Cancer Manag Res. 13:2419–2431. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Guo W, Zhu Y, Pu X, Guo H and Gan W:
Clinical and pathological heterogeneity of four common fusion
subtypes in Xp11.2 translocation renal cell carcinoma. Front Oncol.
13:11166482023. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Karashima T, Kuno T, Kuroda N, Satake H,
Fukata S, Chikazawa M, Kawada C, Yamasaki I, Shuin T, Hiroi M and
Inoue K: Bilateral Xp11.2 translocation renal cell carcinoma: A
case report. BMC Urol. 18:1062018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang P, Zhang X, Shao SH, Wu F, Du FZ,
Zhang JF, Zuo ZW and Jiang R: Chemotherapy, transarterial
chemoembolization, and nephrectomy combined treated one giant renal
cell carcinoma (T3aN1M1) associated with Xp11.2/TFE3: A case
report. World J Clin Cases. 10:10180–10185. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ellis CL, Eble JN, Subhawong AP,
Martignoni G, Zhong M, Ladanyi M, Epstein JI, Netto GJ and Argani
P: Clinical heterogeneity of Xp11 translocation renal cell
carcinoma: Impact of fusion subtype, age, and stage. Mod Pathol.
27:875–886. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lopez-Beltran A, Scarpelli M, Montironi R
and Kirkali Z: 2004 WHO classification of the renal tumors of the
adults. Eur Urol. 49:798–805. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Argani P, Lui MY, Couturier J, Bouvier R,
Fournet JC and Ladanyi M: A novel CLTC-TFE3 gene fusion in
pediatric renal adenocarcinoma with t(X;17)(p11.2;q23). Oncogene.
22:5374–5378. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Clark J, Lu YJ, Sidhar SK, Parker C, Gill
S, Smedley D, Hamoudi R, Linehan WM, Shipley J and Cooper CS:
Fusion of splicing factor genes PSF and NonO (p54nrb) to the TFE3
gene in papillary renal cell carcinoma. Oncogene. 15:2233–2239.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mathur M, Das S and Samuels HH: PSF-TFE3
oncoprotein in papillary renal cell carcinoma inactivates TFE3 and
p53 through cytoplasmic sequestration. Oncogene. 22:5031–5044.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Argani P and Ladanyi M: Translocation
carcinomas of the kidney. Clin Lab Med. 25:363–378. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ramphal R, Pappo A, Zielenska M, Grant R
and Ngan BY: Pediatric renal cell carcinoma: Clinical, pathologic,
and molecular abnormalities associated with the members of the mit
transcription factor family. Am J Clin Pathol. 126:349–364. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sukov WR, Hodge JC, Lohse CM, Leibovich
BC, Thompson RH, Pearce KE, Wiktor AE and Cheville JC: TFE3
rearrangements in adult renal cell carcinoma: Clinical and
pathologic features with outcome in a large series of consecutively
treated patients. Am J Surg Pathol. 36:663–670. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xu L, Yang R, Gan W, Chen X, Qiu X, Fu K,
Huang J, Zhu G and Guo H: Xp11.2 translocation renal cell
carcinomas in young adults. BMC Urol. 15:572015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wu Y, Chen S, Zhang M, Liu K, Jing J, Pan
K, Zhang L, Xu B, Lu X and Chen M: Factors associated with survival
from Xp11.2 translocation renal cell carcinoma diagnosis-A
systematic review and pooled analysis. Pathol Oncol Res.
27:6103602021. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang Y, Wang Y, Feng M, Lian X, Lei Y and
Zhou H: Renal cell carcinoma associated with Xp11.2
translocation/transcription factor E3 gene fusion: An adult case
report and literature review. J Int Med Res.
48:3000605209420952020.PubMed/NCBI
|
|
19
|
Hung CC, Pan CC, Lin CC, Lin ATL, Chen KK
and Chang YH: XP11.2 translocation renal cell carcinoma: Clinical
experience of Taipei Veterans General Hospital. J Chin Med Assoc.
74:500–504. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Armah HB and Parwani AV: Xp11.2
translocation renal cell carcinoma. Arch Pathol Lab Med.
134:124–129. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lim B, You D, Jeong IG, Kwon T, Hong S,
Song C, Cho YM, Hong B, Hong JH, Ahn H and Kim CS:
Clinicopathological features of Xp11.2 translocation renal cell
carcinoma. Korean J Urol. 56:212–217. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chen X, Zhu Q, Li B, Cui W, Zhou H, Duan
N, Liu Y, Kundra V and Wang Z: Renal cell carcinoma associated with
Xp11.2 translocation/TFE gene fusion: Imaging findings in 21
patients. Eur Radiol. 27:543–552. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Dong H, Ni Y, Liu Z, Wang Z, Hu B, Xu H
and Cai S: Imaging findings, clinical and pathological characters
of 28 patients with Xp11.2/TFE3 translocation renal cell carcinoma.
J Cancer Res Ther. 19:132–140. 2023.PubMed/NCBI
|
|
24
|
Wang W, Ding J, Li Y, Wang C, Zhou L, Zhu
H and Peng W: Magnetic resonance imaging and computed tomography
characteristics of renal cell carcinoma associated with Xp11.2
translocation/TFE3 gene fusion. PLoS One. 9:e999902014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liu K, Xie P, Peng W and Zhou Z: Renal
carcinomas associated with Xp11.2 translocations/TFE3 gene fusions:
Findings on MRI and computed tomography imaging. J Magn Reson
Imaging. 40:440–447. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ge Y, Lin X, Zhang Q, Lin D, Luo L, Wang H
and Li Z: Xp11.2 translocation renal cell carcinoma with TFE3
rearrangement: Distinct morphological features and prognosis with
different fusion partners. Front Oncol. 11:7849932021. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Al-Maghrabi JA and Khabaz MN: Uncommon
localization of extrarenal Xp11.2 translocation-associated renal
cell carcinoma (RCC): Case report. Appl Immunohistochem Mol
Morphol. 28:e33–e35. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhou J, Zhao L, Yang Z, Chen Y, Wu X and
Xue W: Clinicopathologic, treatment and prognosis study of 46
Xp11.2 translocation/TFE3 gene fusion renal cell carcinomas. BMC
Urol. 22:1092022. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Liu N, Qu F, Wei K, Gan W, Wang Z, Zhuang
W, Agizamhan S, Ma W, Yang J, Chen M, et al: Incidence and
significance of psammoma bodies in Xp11.2 translocation renal cell
carcinoma and papillary renal cell carcinoma. Oncol Lett.
18:472–478. 2019.PubMed/NCBI
|
|
30
|
Manucha V, Sessums MT, Lewin J and Akhtar
I: Cyto-histological correlation of Xp11.2 translocation/TFE3 gene
fusion associated renal cell carcinoma: Report of a case with
review of literature. Diagn Cytopathol. 46:267–270. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Argani P, Lal P, Hutchinson B, Lui MY,
Reuter VE and Ladanyi M: Aberrant nuclear immunoreactivity for TFE3
in neoplasms with TFE3 gene fusions: A sensitive and specific
immunohistochemical assay. Am J Surg Pathol. 27:750–761. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Dey B, Badhe B, Govindarajan KK and Ramesh
RA: Xp11.2 translocation renal cell carcinoma diagnosed by
immunohistochemistry and cytogenetics. J Lab Physicians. 8:123–125.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Qu Y, Gu C, Wang H, Chang K, Yang X, Zhou
X, Dai B, Zhu Y, Shi G, Zhang H and Ye D: Diagnosis of adults
Xp11.2 translocation renal cell carcinoma by immunohistochemistry
and FISH assays: Clinicopathological data from ethnic Chinese
population. Sci Rep. 6:216772016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Klatte T, Streubel B, Wrba F, Remzi M,
Krammer B, de Martino M, Waldert M, Marberger M, Susani M and
Haitel A: Renal cell carcinoma associated with transcription factor
E3 expression and Xp11.2 translocation: Incidence, characteristics,
and prognosis. Am J Clin Pathol. 137:761–768. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Gaillot-Durand L, Chevallier M, Colombel
M, Couturier J, Pierron G, Scoazec JY and Mege-Lechevallier F:
Diagnosis of Xp11 translocation renal cell carcinomas in adult
patients under 50 years: Interest and pitfalls of automated
immunohistochemical detection of TFE3 protein. Pathol Res Pract.
209:83–89. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhuang W, Liu N, Guo H, Zhang C and Gan W:
Gender difference analysis of Xp11.2 translocation renal cell
carcinomas's attack rate: A meta-analysis and systematic review.
BMC Urol. 20:1302020. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Malouf GG, Su X, Yao H, Gao J, Xiong L, He
Q, Compérat E, Couturier J, Molinié V, Escudier B, et al:
Next-generation sequencing of translocation renal cell carcinoma
reveals novel RNA splicing partners and frequent mutations of
chromatin-remodeling genes. Clin Cancer Res. 20:4129–4140. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kim SH, Choi Y, Jeong HY, Lee K, Chae JY
and Moon KC: Usefulness of a break-apart FISH assay in the
diagnosis of Xp11.2 translocation renal cell carcinoma. Virchows
Arch. 459:299–306. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Rao Q, Williamson SR, Zhang S, Eble JN,
Grignon DJ, Wang M, Zhou XJ, Huang W, Tan PH, Maclennan GT and
Cheng L: TFE3 break-apart FISH has a higher sensitivity for Xp11.2
translocation-associated renal cell carcinoma compared with TFE3 or
cathepsin K immunohistochemical staining alone: Expanding the
morphologic spectrum. Am J Surg Pathol. 37:804–815. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Song HC, Sun N, Zhang WP, He L, Fu L and
Huang C: Biological characteristics of pediatric renal cell
carcinoma associated with Xp11.2 translocations/TFE3 gene fusions.
J Pediatr Surg. 49:539–542. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Dong J, Xu W, Ji Z and Pan B: Xp11.2
translocation renal cell carcinoma: Clinical characteristics and
potential prognostic predictors. Dis Markers. 2021:56479332021.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Zhong M, De Angelo P, Osborne L,
Paniz-Mondolfi AE, Geller M, Yang Y, Linehan WM, Merino MJ,
Cordon-Cardo C and Cai D: Translocation renal cell carcinomas in
adults: A single-institution experience. Am J Surg Pathol.
36:654–662. 2012. View Article : Google Scholar : PubMed/NCBI
|
